Table 1 Clinical–pathological characteristics of patients and tumours (n = 15)

Age [y]

62.1 ± 4.1 (53–68)*

Weight [kg]

88.8 ± 11.4 (65–109)*

Height [cm]

177.4 ± 6.1 (170–191)*

PSA [ng/mL]

9.4 ± 6.3 (3.5–25.5)*

Injected [¹⁸F]DCFPyL activity [MBq]

312.4 ± 15.9 (280.8–348.2)*

Histology—n(%)

Adenocarcinoma

15 (100)

pT Stage—n(%)

 T2c

7 (46.7)

 T3a

7 (46.7)

 T3b

1 (6.7)

pN Stage—n(%)

 N0

15 (100)

 N1

0 (0)

 NX

0 (0)

pM Stage—n(%)

 M0

15 (100)

 M1

0 (0)

 MX

0 (0)

Gleason score of DIL—n(%)

 6 (3 + 3)

1 (6.7)

 7 (3 + 4)

6 (40.0)

 7 (4 + 3)

5 (33.3)

9 (5 + 4)

3 (20.0)